References
- Benard P., Jeanniot J. P., Braun J. P., Burgat-Sacaze V., Rico A. G. Etude par autoradiographie macroscopique de la distribution de la radioactivité chez les singes macaques ayant reçu du chlorhydrate de minaprine marqué au carbone 14. Le Concours Médical 1981; 103(28 Suppl.)24–27
- Biziere K., Kan J. P., Souilhac J., Muyard J. P., Roncucci R. Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug. Arzneimittel Forschung/Drug Research 1982; 32(II)8, 824–831
- Biziere K., Worms P., Kan J. P., Mandel P., Garatini S., Roncucci R. Minaprine, a new drug with antidepressant properties. Drugs under Experimental and Clinical Research 1985; 11: 831–840
- Bohacek N., Ravic M., Biziere K. Minaprine and imipramine in the treatment of major depressive disorders: a comparative double-blind study. Drugs under Experimental and Clinical Research 1987; 13: 435–442
- Caccia S., Fossati T., Mancinelli A. Disposition and metabolism of minaprine in the rat. Xenobiotica 1985; 15(12)1111–1119
- Cailleux A., Leguay D., Wartel R., Patay M., Allain P. Etude pharmacocinétique de la minaprine après administration d'une dose unique par voie orale chez l'homme. Thérapie 1982; 37(1)45–51
- Davi H., Dupont P., Jeanniot J. P., Roncucci R., Cautreels W. The biotransformation of 14C-minaprine in man and five animal species. Xenobiotica 1981; 11(11)735–747
- Davi H., Carayon A., Marti E., Sales Y., Cautreels W. Circulating and brain metabolites of minaprine in the baboon. Xenobiotica 1985; 15(2)97–106
- Djian J., Sevestre M. Le déficit neurobiologique de la post-cinquantaine: de la physiopathologie à la thérapeutique. La Revue du Praticien 1988, Suppl. 25: 57–64
- Fong M. H., Abbiati A., Benfenatti E., Caccia S. Quantitative analysis of minaprine and some of its metabolites with application to kinetic studies in rats. Journal of Chromatography 1983; 259: 141–149
- Garratini S., Forlone G. L., Tirelli S., Ladinsky H., Consolo S. Neurochemical effects of minaprine, a novel psychotropic drug, on the central cholinergic system of the rat. Psychopharmacology 1984; 82: 210–214
- Mikus P., Biziere K., Bentel U. A controlled study of minaprine and nomifensine in outpatients with masked depression. Clinical Trials Journal 1985; 22: 477–488
- Passeri M., Cucinotta D., De Mello M., Biziere K. Comparison of minaprine and placebo in the Alzheimer's disease and multi-infarct dementia. International Journal of Geriatric Psychiatry 1987; 2: 97–103
- Ward C., Smith M. J., Hopkins R., Rogers H. J., Spector R. G., Robinson J. Clinical pharmacokinetics of minaprine. Toxicology Letters (Amst.) 1986; 31(Suppl.)176
- Wermuth C. G., Biziere K., Davi H. Derivatives of 4-methyl-6-phenylpyridazine active on the central nervous system. United States Patent number 4, 1986, 576–946
- Westwood B. E., Harman P. J., Mashford M. L. Liquid chromatographic assay for debrisoquine and 4-hydroxydebrisoquine in urine. Journal of Chromatogtaphy, Biomedical Applications 1986; 374: 200–203
- Worms P., Kan J. P., Perio A., Wermuth C. G., Biziere K., Roncucci R. Profil pharmacologique d'un psychotrope original, la minaprine. Comparaison avec six antidépresseurs de référence. Journal of Pharmacology (Paris) 1986; 17: 126–138
- Worms P., Kan J. P., Steinberg R., Terranova J. P., Perio A., Biziere K. Cholinomimetic activities of minaprine. Naunyn-Schmiedeberg's Archives of Pharmacology 1989; 340: 411–418